Share Name Share Symbol Market Type Share ISIN Share Description
Vastox Plc LSE:VOX London Ordinary Share GB00B02T3K57 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 118.07p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Unknown 1.0 -3.5 -8.2 - 0.00

Vastox Share Discussion Threads

Showing 1 to 12 of 25 messages
Chat Pages: 1
DateSubjectAuthorDiscuss
02/8/2007
17:36
I've created a new thread for Summit Corporation (SUMM). This one is now deceased. There will be a quiet ceremony, family and close friends only please.
gwr7
25/7/2007
21:02
recent con to Summitt has caused a new ticker of SUMM to be issued.
grim
16/5/2007
17:31
Momentum building within the company is not reflected in the share price. Let it sleep while you build your stake. It will rise when it's ready.
gwr7
09/5/2007
18:55
Keep it to yourself or there'll be a stampede.
gwr7
01/5/2007
06:09
an interesting little nugget? http://www.market-insider.net/?p=2244
maiseymouse
01/5/2007
06:09
an interesting little nugget? http://www.market-insider.net/?p=2244
maiseymouse
29/3/2007
08:13
CE purchases shares, results announcement pushed back one week to 29th May to accomodate and closed period now starts today. Three directors obtained shares yesterday probably in lieu of salary as announced earlier.
gwr7
23/3/2007
10:04
Director share purchase reported on 22nd March, last day before 2 month closed period prior to results on 22nd May. Could be significant.
gwr7
06/3/2007
11:21
This one is a bit too early stage for me. Its well funded and has some interesting ideas, but they are probably a couple of years away even from PI trials. I'm not sure either whether it is a drug discovery group or a speciality services group or both (I think they are better focusing in one area). Perhaps one for the future.
dr biotech
13/2/2007
18:08
Hello, is there anybody out there?
gwr7
21/10/2004
10:47
post removed by ADVFN
siri_edit
20/10/2004
08:48
http://www.vastox.com/i/navi/logo.gif"> VASTox plc, the Oxford-based drug discovery and services business focused on chemical genomics, announces its intention to join the Alternative Investment Market (AIM) by way of a Placing. The Company has early-stage proprietary research programmes in Duchenne Muscular Dystrophy and Tuberculosis and also has revenue-generating contracts for the provision of drug discovery services with several pharmaceutical and biotechnology companies via its chemical genomics platform. VASTox was formed as a spin-out company in January 2003 by a prestigious team of scientific founders from the University of Oxford headed by Professor Steve Davies, the chemistry professor who in 1992 founded Oxford Asymmetry, a business that was eventually sold for £316 million. Professor Steve Davies is VASTox's Non-executive Chairman and its Chief Executive Officer is Dr Steven Lee, the former executive director of Life Sciences at IP2IPO Group plc During the past four years, VASTox's scientific founders whose experience brings together chemistry and biology in an effort to find new treatments for human disease, have collaborated extensively in the development of chemical genomics, the use of small molecule drugs to influence complex cellular pathways. Through its founders, the Company has extensive expertise in the use and understanding of small animal models, in particular Danio rerio (zebrafish) and Drosophila (fruitflies), and applying this to human disease.
cezary
Chat Pages: 1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161209 11:41:33